Oncology Brothers made the following post on X:
“Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3: NALIRIFOX vs. Gem/Abrax
- mOS 11.1mos Vs 9.2mos (HR: 0.83)
- Cross trial comparison, similar OS w/ FOLFIRINIOX
- Save liposomal for later lines?”
Source: Oncology Brothers/X